_version_ 1783504175906160640
author Wan, Yi Ching Esther
Leung, Tsz Chui Sophia
Ding, Dongbo
Sun, Xulun
Liu, Jiaxian
Zhu, Lina
Kang, Tze Zhen Evangeline
Yang, Du
Zhang, Yuchen
Zhang, Jitian
Qian, Chengmin
Huen, Michael Shing Yan
Li, Qing
Chow, Maggie Zi Ying
Zheng, Zongli
Han, Junhong
Goel, Ajay
Wang, Xin
Ishibashi, Toyotaka
Chan, Kui Ming
author_facet Wan, Yi Ching Esther
Leung, Tsz Chui Sophia
Ding, Dongbo
Sun, Xulun
Liu, Jiaxian
Zhu, Lina
Kang, Tze Zhen Evangeline
Yang, Du
Zhang, Yuchen
Zhang, Jitian
Qian, Chengmin
Huen, Michael Shing Yan
Li, Qing
Chow, Maggie Zi Ying
Zheng, Zongli
Han, Junhong
Goel, Ajay
Wang, Xin
Ishibashi, Toyotaka
Chan, Kui Ming
author_sort Wan, Yi Ching Esther
collection PubMed
description
format Online
Article
Text
id pubmed-7060176
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-70601762020-03-19 Cancer-associated histone mutation H2BG53D disrupts DNA–histone octamer interaction and promotes oncogenic phenotypes Wan, Yi Ching Esther Leung, Tsz Chui Sophia Ding, Dongbo Sun, Xulun Liu, Jiaxian Zhu, Lina Kang, Tze Zhen Evangeline Yang, Du Zhang, Yuchen Zhang, Jitian Qian, Chengmin Huen, Michael Shing Yan Li, Qing Chow, Maggie Zi Ying Zheng, Zongli Han, Junhong Goel, Ajay Wang, Xin Ishibashi, Toyotaka Chan, Kui Ming Signal Transduct Target Ther Letter Nature Publishing Group UK 2020-03-06 /pmc/articles/PMC7060176/ /pubmed/32296031 http://dx.doi.org/10.1038/s41392-020-0131-0 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Letter
Wan, Yi Ching Esther
Leung, Tsz Chui Sophia
Ding, Dongbo
Sun, Xulun
Liu, Jiaxian
Zhu, Lina
Kang, Tze Zhen Evangeline
Yang, Du
Zhang, Yuchen
Zhang, Jitian
Qian, Chengmin
Huen, Michael Shing Yan
Li, Qing
Chow, Maggie Zi Ying
Zheng, Zongli
Han, Junhong
Goel, Ajay
Wang, Xin
Ishibashi, Toyotaka
Chan, Kui Ming
Cancer-associated histone mutation H2BG53D disrupts DNA–histone octamer interaction and promotes oncogenic phenotypes
title Cancer-associated histone mutation H2BG53D disrupts DNA–histone octamer interaction and promotes oncogenic phenotypes
title_full Cancer-associated histone mutation H2BG53D disrupts DNA–histone octamer interaction and promotes oncogenic phenotypes
title_fullStr Cancer-associated histone mutation H2BG53D disrupts DNA–histone octamer interaction and promotes oncogenic phenotypes
title_full_unstemmed Cancer-associated histone mutation H2BG53D disrupts DNA–histone octamer interaction and promotes oncogenic phenotypes
title_short Cancer-associated histone mutation H2BG53D disrupts DNA–histone octamer interaction and promotes oncogenic phenotypes
title_sort cancer-associated histone mutation h2bg53d disrupts dna–histone octamer interaction and promotes oncogenic phenotypes
topic Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7060176/
https://www.ncbi.nlm.nih.gov/pubmed/32296031
http://dx.doi.org/10.1038/s41392-020-0131-0
work_keys_str_mv AT wanyichingesther cancerassociatedhistonemutationh2bg53ddisruptsdnahistoneoctamerinteractionandpromotesoncogenicphenotypes
AT leungtszchuisophia cancerassociatedhistonemutationh2bg53ddisruptsdnahistoneoctamerinteractionandpromotesoncogenicphenotypes
AT dingdongbo cancerassociatedhistonemutationh2bg53ddisruptsdnahistoneoctamerinteractionandpromotesoncogenicphenotypes
AT sunxulun cancerassociatedhistonemutationh2bg53ddisruptsdnahistoneoctamerinteractionandpromotesoncogenicphenotypes
AT liujiaxian cancerassociatedhistonemutationh2bg53ddisruptsdnahistoneoctamerinteractionandpromotesoncogenicphenotypes
AT zhulina cancerassociatedhistonemutationh2bg53ddisruptsdnahistoneoctamerinteractionandpromotesoncogenicphenotypes
AT kangtzezhenevangeline cancerassociatedhistonemutationh2bg53ddisruptsdnahistoneoctamerinteractionandpromotesoncogenicphenotypes
AT yangdu cancerassociatedhistonemutationh2bg53ddisruptsdnahistoneoctamerinteractionandpromotesoncogenicphenotypes
AT zhangyuchen cancerassociatedhistonemutationh2bg53ddisruptsdnahistoneoctamerinteractionandpromotesoncogenicphenotypes
AT zhangjitian cancerassociatedhistonemutationh2bg53ddisruptsdnahistoneoctamerinteractionandpromotesoncogenicphenotypes
AT qianchengmin cancerassociatedhistonemutationh2bg53ddisruptsdnahistoneoctamerinteractionandpromotesoncogenicphenotypes
AT huenmichaelshingyan cancerassociatedhistonemutationh2bg53ddisruptsdnahistoneoctamerinteractionandpromotesoncogenicphenotypes
AT liqing cancerassociatedhistonemutationh2bg53ddisruptsdnahistoneoctamerinteractionandpromotesoncogenicphenotypes
AT chowmaggieziying cancerassociatedhistonemutationh2bg53ddisruptsdnahistoneoctamerinteractionandpromotesoncogenicphenotypes
AT zhengzongli cancerassociatedhistonemutationh2bg53ddisruptsdnahistoneoctamerinteractionandpromotesoncogenicphenotypes
AT hanjunhong cancerassociatedhistonemutationh2bg53ddisruptsdnahistoneoctamerinteractionandpromotesoncogenicphenotypes
AT goelajay cancerassociatedhistonemutationh2bg53ddisruptsdnahistoneoctamerinteractionandpromotesoncogenicphenotypes
AT wangxin cancerassociatedhistonemutationh2bg53ddisruptsdnahistoneoctamerinteractionandpromotesoncogenicphenotypes
AT ishibashitoyotaka cancerassociatedhistonemutationh2bg53ddisruptsdnahistoneoctamerinteractionandpromotesoncogenicphenotypes
AT chankuiming cancerassociatedhistonemutationh2bg53ddisruptsdnahistoneoctamerinteractionandpromotesoncogenicphenotypes